Evidence map›Paper›PMID 32647795›Full record

ArticleHemaSphere2020

Development of a Patient Centered Outcome Set for Patients With Multiple Myeloma to be Used in Clinical Practice.

Simone Oerlemans, M Christine Bennink, Mark David Levin, Annemiek Broijl, Marjolein Van der Klift, Judith Van Deursen, Daphne Vogels, Lonneke V Van de Poll-Franse, Pieter Sonneveld, Jan A Hazelzet and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Value in Myeloma Care: Myth or Reality.Current hematologic malignancy reports · 2022
    Review
  4. Health Outcomes Management Evaluation-A National Analysis of Dutch Heart Care.European heart journal. Quality of care & clinical outcomes · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Simone OerlemansDepartment of Research and development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.
M Christine BenninkDepartment of Strategy, Amphia, Breda, the Netherlands.
Mark David LevinDepartment of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Annemiek BroijlDepartment of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Marjolein Van der KliftDepartment of Internal Medicine, Amphia, Breda, the Netherlands.
Judith Van DeursenDepartment of Internal Medicine, Amphia, Breda, the Netherlands.
Daphne VogelsDepartment of Internal Medicine, Máxima Medical Centre, Eindhoven and Veldhoven, the Netherlands.
Lonneke V Van de Poll-FranseDepartment of Research and development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.
Pieter SonneveldDepartment of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Jan A HazelzetDepartment of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.
Lidwine W TickDepartment of Internal Medicine, Máxima Medical Centre, Eindhoven and Veldhoven, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32647795
PMCPMC7306300

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.